TargetMol®高溶解性微型片段庫

The compound library of highly soluble micro-fragments consists of 1082 low-molecular-weight fragments. Low-molecular-weight compounds (so-called micro-fragments) are derived from commercially available fragment spaces. The focus is on ensuring the chemical stability of the compound, the absence of reactive compounds, meeting the physical and chemical characteristics of the screening, and not strictly complying with the drug similarity standards, the structural diversity of compounds/covering a wider chemical space, aims to provide hit drug targets for the fields of new drug discovery and drug design.
 

TargetMol®高溶解性微型片段庫Product Description

Traditional drug research and development are mainly based on natural active products or screening new drugs from existing compound data, but this method is highly random, blind, and inefficient. Medicinal chemists subsequently developed high-throughput screening (HTS) methods for drug discovery. Many pharmaceutical companies have also established compound libraries containing millions of small molecules and discovered many drug candidates. However, in drug screening with complex targets, HTS has been repeatedly frustrated. It is difficult to screen high-potential compounds, or the screened compounds have high false positives and poor drug-like properties. In this context, Fragment-based drug design (FBDD) came into being.

Feature：

1. The chemical properties are stable, the structure is diverse, and the chemical space is widely distributed;

2. Each fragment has been tested for solubility: DMSO (200 mM) and PBS (1 mM);

3. The molecular weight of most fragments is less than 300, and the number of hydrogen bond donors and acceptors is not higher than 3;

4. Strict quality control, and the purity of the compounds is above 95%;

化合物庫定制

我們的化合物庫可以靈活定制！ 了解更多
 

品牌介紹：
TargetMol Chemicals Inc. 總部位于馬薩諸塞州波士頓，致力于為全球生化域科學(xué)家的研究提供業(yè)的產(chǎn)品和服務(wù)。TargetMol品牌的客戶群分布于40多個(gè)國家和地區(qū)，已發(fā)展成為全球大的化合物庫和小分子化合物研究供應(yīng)商之一。

☆ TargetMol®品牌業(yè)提供各域信號通路小分子抑制劑、拮抗劑、天然產(chǎn)物、藥物篩選化合物。
☆ 產(chǎn)品適應(yīng)在癌癥、免疫學(xué)、心血管系統(tǒng)、呼吸、神經(jīng)科學(xué)等多項(xiàng)科學(xué)域的研發(fā)使用，超過1180萬種小分子化合物。
☆ 提供20000多個(gè)小分子抑制劑、天然產(chǎn)物和200多個(gè)化合物庫。
☆ 配備完善的化學(xué)合成和生物實(shí)驗(yàn)室，可分別提供高品質(zhì)小分子抑制劑和藥物篩選技術(shù)服務(wù)。
☆ 每批產(chǎn)品都有嚴(yán)格的NMR和HPLC技術(shù)檢測，以保證產(chǎn)品高純度高質(zhì)量。